Antibacterial activity of hinokitiol against both antibiotic‐resistant and ‐susceptible pathogenic bacteria that predominate in the oral cavity and upper airways

Hisanori Domon,Takumi Hiyoshi,Tomoki Maekawa,Daisuke Yonezawa,Hikaru Tamura,Shigetada Kawabata,Katsunori Yanagihara,Osamu Kimura,Eiji Kunitomo,Yutaka Terao

DOI: https://doi.org/10.1111/1348-0421.12688

2019-06-01

Microbiology and Immunology

Abstract:Hinokitiol is a component of the essential oil isolated from Cupressaceae. It possesses antibacterial and antifungal activities and has been used in oral care products. In this study, we examined the antibacterial activities of hinokitiol toward various oral, nasal, and nasopharyngeal pathogenic bacteria, including Streptococcus mutans, Streptococcus sobrinus, Porphyromonas gingivalis, Aggregatibacter actinomycetemcomitans, Prevotella intermedia, Fusobacterium nucleatum, methicillin‐resistant and ‐susceptible Staphylococcus aureus, antibiotic‐resistant and ‐susceptible Streptococcus pneumoniae, and Streptococcus pyogenes. The growth of all bacterial strains was significantly inhibited by hinokitiol. The minimal inhibitory concentrations of hinokitiol against S. mutans, S. sobrinus, P. gingivalis, P. intermedia, A. actinomycetemcomitans, F. nucleatum, methicillin‐resistant S. aureus, methicillin‐susceptible S. aureus, antibiotic‐resistant S. pneumoniae isolates, antibiotic‐susceptible S. pneumoniae, and S. pyogenes were 0.3, 1.0, 1.0, 30, 0.5, 50, 50, 30, 0.3–1.0, 0.5, and 0.3 μg/mL, respectively. Additionally, with the exception of P. gingivalis, hinokitiol exerted bactericidal effects against all bacterial strains at 1 h after exposure. Hinokitiol did not display any significant cytotoxicity toward the human gingival epithelial cell line Ca9‐22, pharyngeal epithelial cell line Detroit 562, human umbilical vein endothelial cells, and human gingival fibroblasts, with the exception of 500 μg/mL hinokitiol treatment, which decreased viable Ca9‐22 cells and gingival fibroblasts by 13% and 12%, respectively. These results suggest that hinokitiol exhibits antibacterial activity against a broad spectrum of pathogenic bacteria and low cytotoxicity towards human epithelial cells.This article is protected by copyright. All rights reserved.

immunology,microbiology